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Introduction:
Anaemia is a condition in which the oxygen carrying 
capacity of  the red blood cells is insufficient to meet 
the body physiological needs. It can cause various 
health complications in every age group including preg-
nant women, wherein it can lead to adverse maternal 
and foetal outcomes[1]. It is estimated that as many as 
20% of  maternal deaths are directly caused by anaemia 
through its complications and it is an associated cause in 
as many as 50% of  maternal deaths worldwide[1],[2]. The 
World Health Organization (WHO) defines anaemia as 
blood hemoglobin concentration less than 11gm/dl or 
hematocrit less than 37% in pregnant women [1]. The 
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The prevalence of  anaemia among pregnant women in 
Karnataka State in India is 62.6% [3].  Iron deficiency 
is thought to be the most common cause of  anaemia 
globally, accounting for more than half  of  anaemia 
cases in pregnancy [1].     
Iron, is an essential nutrient, which is required for 
haemoglobin synthesis, other than the normal well-
being, whose demand increases highly during pregnancy 
and many times does not get supplied through the 
regular diet. This can be worsened by the loss of  appetite 
during pregnancy[4]. Therefore the most suitable mass 
intervention for iron supplementation is administering 
Iron along with Folic acid in the form of  tablets to 
pregnant women aimed at increasing the haemoglobin 
concentration, so that the level of  anaemia at term 
could be reduced to the best possible extent [5],[6],[7].
Most Ministries of  Health in developing countries have 
policies to give pregnant women either iron by itself  or 
combined with folic acid in tablet form (IFA tablets). 
The National protocols in India require the provision 
of  1 tablet containing 100 mg elemental iron and 0.5 
mg folic acid for daily consumption to all women during 
pregnancy for 100 days. 
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Abstract
Background: Anaemia is highly prevalent among pregnant women and iron deficiency is the most important cause. Like 
many other countries, India has policies to give pregnant women iron supplements. Non-compliance is one important chal-
lenging factor in combating anaemia. 
Objective: To estimate the compliance for IFA tablets among pregnant women and to study the social factors influencing 
it.
Methodology: This study included 190 pregnant women seeking ante-natal care in tertiary health Centres in the Mangalore 
city in South India. After Institutional Ethics Committee (IEC) approval, data was collected by personal interview. Missing 
≥2 doses consecutively was considered non-compliance. The data was analyzed using SPSS (Statistical Package for Social 
Sciences) version 11.5. 
Results: The mean age of  the study population was 25.8 years (SD: 4.1). Majority of  the subjects consumed mixed diet and 
72.1% belonged to lower socioeconomic status. Overall, compliance with IFA tablets was 64.7%. Compliance increased with 
the increase in age, birth order and single daily dose. Forgetfulness and both perceived as well as experienced side effects of  
IFA therapy were the important factors for non-compliance. 
Conclusion: There was a moderate level of  Compliance towards IFA tablets with key social and demographic factors play-
ing important role.
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But effectiveness and success of  such interventions 
depend on the compliance to the Iron-folic acid tablets. 
Compliance describes the degree to which a patient 
correctly follows a medical advice. Many experts 
believe that one of  the main reasons that national 
iron supplementation programs have failed is women’s 
“noncompliance” [1],[5]. There are factors including 
health system and patient factors which determine the 
compliance, which are not studied extensively [5],[6] . 
There are no clear cut offs for non-compliance. Missing 
2 or more doses consecutively is usually considered as 
non-compliance [4]. 
Thus compliance is essential for Iron Folic Acid 
therapy which in turn is influenced by several social 
and demographic factors. This study was carried out 
in a tertiary care centers in Mangalore to assess the 
awareness, practices, level of  compliance and the factors 
affecting the level of  compliance among the pregnant 
women with iron folic acid therapy. 
Materials and Methods:
This hospital based cross sectional study was carried out 
in the Lady Goschen Hospital and Kasturba Medical 
College Hospital Attavar, which are tertiary care centers 
providing Mother and Child Health services affiliated 
as teaching hospitals to Kasturba Medical College (Ma-
nipal University) Mangalore. The study was carried out 
for a period of  two months (January-February 2012). 
The pregnant women attending the Antenatal Care clin-
ic in the study hospital during the study period were in-
cluded as the subjects in the study. The sample size was 
calculated using anticipated 33% non-compliance with 
IFA tablets[4], with 7% absolute precision, 95% confi-
dence interval and 10% non-response error, as 190. 
After obtaining clearance from the Institutional Ethics 
Committee (IEC) and permission from the Hospital 
Authorities, the hospitals were visited for data collection. 
The subjects were selected using non-random sampling 
method (convenient sampling) till the required sample 
size of  190 was reached. The study subjects were 
explained about the objectives of  the study in their 
vernacular language in clear words, were provided with 
the information sheet and a written informed consent 
was obtained from each of  the subjects. Those who 
were not willing to participate were excluded from the 
study. The data was collected by using a pretested, semi-
structured proforma, which included the demographic 
information, questions on practices related to Iron 
Folic Acid therapy, the number of  doses including 
therapeutic purposes, their compliance and factors 
related to missing of  the doses, followed by observing 
their latest hemoglobin levels from their records at the 
time of  the interview. The socioeconomic status was 
calculated using Modified Kuppuswamy Scale[7] and for 
analyses, the classes were resorted as Upper and Lower. 
Missing of  two or more doses of  IFA was considered 
as non-compliance [4]. Hemoglobin level was classified 
according to the WHO recommendations [1]. 
The collected data was coded and entered into the SPSS 
(Statistical Package for Social Sciences) version 11.5. 
The results were expressed as proportions. To compare 
the differences across the groups, chi square test was 
used and p value <0.05 was considered statistically 
significant. 
Results:
The study included 190 women attending the Ante-
natal Clinics. The socio-demographic characteristics 
associated with the compliance towards consumption 
of  IFA tablets is depicted in Table1. Among the study 
participants, majority (80.6%) belonged to 21-30 years 
age group and 72.1% belonged to Lower socioeconom-
ic status. The mean age of  the study population was 
25.8 years (SD: 4.1). Overall, 84.7% consumed mixed 
diet and 15.3% had predominant vegetarian diet. Also, 
24.2% subjects were anaemic and among them, only 
58.7% consumed all the IFA tablets given to them. Also 
66.8% of  the subjects received the therapy free of  cost, 
since they attended the ANCs in Public Hospitals. In 
total, 73.2% of  the study population was aware about 
the importance of  IFA tablets. 
The overall compliance towards IFA tablets among 
the subjects was 64.7%. As depicted in Table 1, the 
compliance was higher among the subjects from lower 
socioeconomic class, with increasing age and birth, which 
were found to be statistically significant (p<0.05). The 
compliance was higher among the subjects with mixed 
diet. But the difference was not statistically significant. 
The subjects who received the IFA tablets free of  
cost had significantly higher compliance (p=0.029) as 
compared to those from the private hospital who had 
to spend money for it.
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<25 years 57 (57.6) 42 (42.4) 0.031*
>25 years 66 (72.5) 25 (27.5)
Socio economic status 
(SES)
Upper 19 (38.8) 30 (61.2) 0.001*
Lower 104 (73.8) 37 (26.2)
Predominant Diet
Vegetarian 16 (55.2) 13 (44.8)
0.242
Mixed 107 (66.5) 54 (33.5)
Hemoglobin status
Anaemic# 27 (58.7) 19 (41.3)
0.471
Normal 96 (66.7) 48 (33.3)
Order of  pregnancy
First 15 (46.9) 17 (53.1)
Second and above 108 (68.4) 50 (31.6) 0.020*
Tablets per day
One 84 (67.7) 40 (32.3)
0.235
Two or more 39 (59.1) 27 (40.9)
Cost of  the tablets
Free 89 (70.1) 38 (29.9)
0.029*Purchase 34 (54.0) 29 (46.0)
*-significant at p =0.05, Anaemia – Blood Haemoglobin concentration < 11 gram/dl [1]
Further, the independent factors contributing towards 
the compliance were included in the Multiple Logistic 
Regression analysis and depicted in Table 2. The 
variables included in the regression analysis were age 
group, socioeconomic status (SES), predominant diet, 
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Haemoglobin status, order of  pregnancy, number of  
IFA tablets per day, cost of  the IFA tablets. The findings 
were similar to that of  uni-variate analysis. SES, age 
group, order of  pregnancy and cost of  IFA tablets had 
the highest contribution towards the compliance. 
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Table 2 Correlates of  Compliance to IFA tablets among the subjects: Step-wise multiple logistic regression 
analysis (n=190)





(Adjusted) 95% CI p value
Age group
<25 years 1 -- -- -- --
>25 years 2.06 0.81-3.31 2.39 0.94-5.59 0.001
Socio economic status
Upper 1 -- -- -- --
Lower 6.3 2.4-10.2 8.2 2.8-13.6 <0.001
Predominant Diet
Vegetarian 1 -- -- -- --
Mixed 1.21 0.68-2.2 1.9 1.10-3.82 0.04
Hemoglobin status
Anaemic 1 --                                            --               -- --
Normal 1.32 0.79-2.3 1.8 1.20-4.12 0.02
Order of  pregnancy
First 1 -- -- -- --
Second and above 4.62 0.62-16.34 3.67 0.45-20.25 <0.001
Tablets per day
Two or more 1 -- -- -- --
One 1.2 0.3-2.1 1.5 0.4-2.6 0.07
Cost of  the tablets
Purchase 1 -- -- -- --
Free  3.4 1.2-5.6 3.7 1.6-5.8 0.001
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The study subjects also had perceived side-effects with 
IFA, which included vomiting (47.69%), constipation 
(21.54%) and gastritis (13.84%).  The reasons for skip-
ping the IFA doses among the non-compliant subjects 
are given in Table 3. The main reason for skipping the 
dose is forgetfulness (48.8%) followed by travel, consti-
pation, gastritis, vomiting and others. 
Among the study subjects, 96.8% were consuming fruits 
along with their usual diet. The main reasons for non-
consumption of  the fruits among the remainder were 
the cost of  fruits, lack of  interest and fear of  developing 
Diabetes Mellitus. Overall, 98.9% of  the subjects were 
consuming vegetables. 
Discussion 
This study found 98% of  the subjects consuming the 
IFA tablets and compliance was (64.7%) which is very 
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similar to a study conducted in Senegal in 2008. [8] The 
reasons for non-compliance as given by the patients in 
our study include: the experience of  side-effects that 
they associated with the tablets, misunderstanding that 
they needed to continue taking the tablets throughout 
pregnancy and forgetfulness which are similar to the 
previous studies.[2],[4] Additional barriers also could in-
clude inadequate counseling and distribution of  iron 
tablets, difficult access and poor utilization of  prenatal 
health care services, beliefs against consuming medi-
cations during pregnancy, and in most countries, fears 
that taking too much iron may cause too much blood or 
a big baby, making delivery more difficult.[2] [9]
According to our study; about 58.1% subjects consumed 
all the IFA tablets given to them. This is in accordance 
with the previous studies done in Karnataka State in 
2006 and 2009.[10],[11] The demographic characteristics 
of  the subjects in our study are in accordance with the 
study conducted by Pena-Rosas et al. [12]
Also our study observed that there are direct and indirect 
factors affecting the compliance levels. Those women, 
who are anaemic, had lesser level of  compliance and the 
women who were above 25, and had second pregnancy 
were more compliant when compared to others. Single 
doses seemed to have higher IFA compliance levels. 
This study is very similar to a study conducted among 
low income group of  women in USA during 2005, on 
pill count adherence to prenatal multivitamin/mineral 
supplement use in which the researchers reported that 
ethnicity, null-gravidity, smoking, educational and marital 
status affected compliance with prescribed medication.
[13].  This however needs further evaluation to determine 
the temporality of  association. Add to that the perceived 
side effects, consciousness about the tablets provided, 
lack of  clarity on the significance of  IFA tablets. The 
present study area reflects a literate population and a 
prospectively developing region. Despite that there are 
factors which hinder the compliance of  IFA tablets 
during pregnancy; thereby increasing the chances of  
skipping the doses. The present study highlights on high 
proportions of  such beliefs and perceptions, similar to 
the Danish 2012 study. [14]
Thus there are many barriers to the successful 
implementation of  IFA therapy among pregnant 
women. There are fears associated with the side effects 
of  IFA tablets either due to perceived or experienced 
effects, inadequate counseling and information on 
significance of  IFA tablets in pregnancy and the 
compliance with them. Reasons like forgetfulness and 
not being able to take the tablets due to travel are the 
important patient factors influencing the compliance, 
which need motivation from the pregnant women and 
demand further in depth behavioural studies. These 
socio demographic factors influencing the compliance 
with IFA tablets and thus determining the anaemia 
status could still be more and adverse in the other parts 
of  the country where, literacy rates and health care 
delivery system are yet to reach the desired target.[9]
Conclusion 
The study population had a moderate level of  compli-
ance towards IFA tablets in pregnancy. The compliance 
level is directly influenced by the age, socioeconomic 
status, cost of  the IFA tablets and birth order. Also, per-
ceived side effects, lack of  clarity on importance of  IFA 
during pregnancy decreased the overall compliance.
Limitations
The cross sectional nature of  the study does not extend 
to the information on complete iron intake during preg-
nancy. There were also chances of  recall bias among the 
study subjects regarding skipping of  IFA doses. 
Recommendations 
During Antenatal visits, the significance of  IFA tablets 
should be repeatedly explained and enforced on. Health 
education sessions should be conducted for pregnant 
mothers on regular basis and the same implementation 
has to be percolated to all cadres of  health service pro-
viders.
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